Back

Maximizing targeted medical therapy for oHCM: from trials to real world

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists Hypertrophic Cardiomyopathy Open Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Iacopo Olivotto

University of Florence, Florence (Italy)

4 More presentations in this session

Presentation thumbnail
Epidemiology and unmet needs of oHCM in the general population - How common is heart failure?
Professor G. Savarese (Stockholm, SE)
Slides Video
Presentation thumbnail
Pathophysiology and rationale for CMIs in HCM and HFpEF
Professor C. Maack (Wuerzburg, DE)
Video
Presentation thumbnail
Case: challenging choice between CMIs and surgery
Doctor M. Michels (Rotterdam, NL)
Video
Presentation thumbnail
Summary
Professor I. Olivotto (Florence, IT)
Video

Access the full session

Session thumbnail
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Management of hypertrophic obstructive cardiomyopathy in 2025
thumbnail
Congress Presentation
Cardiac myosin inhibitors use in the real world: what you need to know
thumbnail
Congress Presentation
A new era in drug treatment for hypertrophic obstructive cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources